## Abstract ## Objectives To investigate the correlation between anosognosia and behavioural symptoms, performance on executive tests, and frontal cortex regional cerebral blood flow (rCBF) in patients with ‘amnestic mild cognitive impairment’ (MCI) and mild Alzheimer's disease (AD). ## Methods
Neural correlates of anosognosia for cognitive impairment in Alzheimer's disease
✍ Scribed by Eric Salmon; Daniela Perani; Karl Herholz; Patricia Marique; Elke Kalbe; Vjera Holthoff; Xavier Delbeuck; Bettina Beuthien-Baumann; Oriana Pelati; Solange Lespagnard; Fabienne Collette; Gaëtan Garraux
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 207 KB
- Volume
- 27
- Category
- Article
- ISSN
- 1065-9471
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
We explored the neural substrate of anosognosia for cognitive impairment in Alzheimer's disease (AD). Two hundred nine patients with mild to moderate dementia and their caregivers assessed patients' cognitive impairment by answering a structured questionnaire. Subjects rated 13 cognitive domains as not impaired or associated with mild, moderate, severe, or very severe difficulties, and a sum score was calculated. Two measures of anosognosia were derived. A patient's self assessment, unconfounded by objective measurements of cognitive deficits such as dementia severity and episodic memory impairment, provided an estimate of impaired self‐evaluative judgment about cognition in AD. Impaired self‐evaluation was related to a decrease in brain metabolism measured with 18F‐2‐fluoro‐2‐deoxy‐D‐glucose positron emission tomography (FDG‐PET) in orbital prefrontal cortex and in medial temporal structures. In a cognitive model of anosognosia, medial temporal dysfunction might impair a comparison mechanism between current information on cognition and personal knowledge. Hypoactivity in orbitofrontal cortex may not allow AD patients to update the qualitative judgment associated with their impaired cognitive abilities. Caregivers perceived greater cognitive impairments than patients did. The discrepancy score between caregiver's and patient's evaluations, an other measure of anosognosia, was negatively related to metabolic activity located in the temporoparietal junction, consistent with an impairment of self‐referential processes and perspective taking in AD. Hum Brain Mapp, 2005. © 2005 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
## Abstract ## Objective to investigate patterns of anosognosia for memory deficit in subjects with amnestic mild cognitive impairment (MCI) and Alzheimer's disease (AD). ## Methods the study involved twenty‐five subjects with MCI, 15 with mild AD and 21 normal controls (NC). Subjective rating o
## Abstract Depression is very common in patients with dementia but the relationship is very complex. Depression is regarded as a cause of excess disability in persons with dementia and contributes to their functional decline. The assessment of depression in dementia patients, however, has been dif
The neural basis of the amnesia characterizing early Alzheimer's disease (AD) remains uncertain. Postmortem pathological studies have suggested early involvement of the mesial temporal lobe, whereas in vivo metabolic studies have shown hypometabolism of the posterior cingulate cortex. Using a techni
## Abstract ## Objectives The aim of the present study was to assess olfactory dysfunction in patients with Alzheimer's disease (AD) and to compare utility of the olfactory tests as possible clinical markers. ## Methods Two olfactory identification tests (The Cross‐Cultural Smell Identification
## Abstract Increasing evidence supports a role for oxidative damage in the pathogenesis of Alzheimer's disease (AD). Multiple studies show significantly increased levels of lipid peroxidation and protein, DNA, and RNA oxidation in vulnerable regions of the brain of patients with late‐stage AD (LAD